Scabies and impetigo in Samoa: A school-based clinical and molecular epidemiological study
暂无分享,去创建一个
J. Lacey | S. Jack | G. Taiaroa | D. Williamson | C. Gorrie | S. Viali | M. Tafuna'i | Ben Matalavea | D. Price | L. Isaia | Hinauri Leaupepe | Darren Y. J. Lee
[1] J. J. Morelli,et al. Longitudinal, strain-specific Staphylococcus aureus introduction and transmission events in households of children with community-associated meticillin-resistant S aureus skin and soft tissue infection: a prospective cohort study. , 2019, The Lancet. Infectious diseases.
[2] A. Ralph,et al. Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease , 2019, PLoS neglected tropical diseases.
[3] J. Kaldor,et al. Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial , 2019, The Lancet. Infectious diseases.
[4] R. Hay,et al. Control of scabies and secondary impetigo: optimising treatment effectiveness in endemic settings. , 2019, The Lancet. Infectious diseases.
[5] J. McVernon,et al. High burden of infectious disease and antibiotic use in early life in Australian Aboriginal communities , 2019, Australian and New Zealand journal of public health.
[6] S. Tong,et al. Treatment, prevention and public health management of impetigo, scabies, crusted scabies and fungal skin infections in endemic populations: a systematic review , 2019, Tropical medicine & international health : TM & IH.
[7] M. Redman-MacLaren,et al. Randomized Trial of Community Treatment With Azithromycin and Ivermectin Mass Drug Administration for Control of Scabies and Impetigo , 2019 .
[8] L. C. Fuller,et al. A Review of Scabies: An Infestation More than Skin Deep , 2018, Dermatology.
[9] Haniye Sadat Sajadi,et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, The Lancet.
[10] A. Steer,et al. Control Strategies for Scabies , 2018, Tropical medicine and infectious disease.
[11] A. Bowen,et al. Scabies and impetigo in Timor-Leste: A school screening study in two districts , 2018, PLoS neglected tropical diseases.
[12] L. C. Fuller,et al. Consensus criteria for the diagnosis of scabies: A Delphi study of international experts , 2018, PLoS neglected tropical diseases.
[13] M. Baker,et al. Group A Streptococcus pharyngitis and pharyngeal carriage: A meta-analysis , 2018, PLoS neglected tropical diseases.
[14] R. Hay,et al. The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015 , 2017, The Lancet. Infectious diseases.
[15] Francesc Coll,et al. Longitudinal genomic surveillance of MRSA in the UK reveals transmission patterns in hospitals and the community , 2017, Science Translational Medicine.
[16] B. Mehramuz,et al. The pathogenesis of Staphylococcus aureus in autoimmune diseases. , 2017, Microbial pathogenesis.
[17] J. Kaldor,et al. The Epidemiology of Scabies and Impetigo in Relation to Demographic and Residential Characteristics: Baseline Findings from the Skin Health Intervention Fiji Trial. , 2017, The American journal of tropical medicine and hygiene.
[18] P. Linden,et al. Incidence, prevalence, and management of MRSA bacteremia across patient populations—a review of recent developments in MRSA management and treatment , 2017, Critical Care.
[19] Jui-Ming Liu,et al. The effects of climate factors on scabies. A 14-year population-based study in Taiwan , 2016, Parasite.
[20] M. Davies,et al. Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development , 2016, BMC Infectious Diseases.
[21] J. Carapetis,et al. Impetigo and scabies - Disease burden and modern treatment strategies. , 2016, The Journal of infection.
[22] J. Kaldor,et al. The Prevalence of Scabies and Impetigo in the Solomon Islands: A Population-Based Survey , 2016, PLoS neglected tropical diseases.
[23] S. Tong,et al. The Importance of Scabies Coinfection in the Treatment Considerations for Impetigo , 2016, The Pediatric infectious disease journal.
[24] G. Karthikeyan,et al. Acute rheumatic fever and rheumatic heart disease , 2015, Nature Reviews Disease Primers.
[25] J. Kaldor,et al. Mass Drug Administration for Scabies Control in a Population with Endemic Disease. , 2015, The New England journal of medicine.
[26] A. Steer,et al. Long Term Control of Scabies Fifteen Years after an Intensive Treatment Programme , 2015, PLoS neglected tropical diseases.
[27] R. Hay,et al. The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma , 2015, PloS one.
[28] M. Baker,et al. M-Protein Analysis of Streptococcus pyogenes Isolates Associated with Acute Rheumatic Fever in New Zealand , 2015, Journal of Clinical Microbiology.
[29] J. Kaldor,et al. Prevalence of scabies and impetigo worldwide: a systematic review. , 2015, The Lancet. Infectious diseases.
[30] J. Kaldor,et al. Scabies and Impetigo Prevalence and Risk Factors in Fiji: A National Survey , 2015, PLoS neglected tropical diseases.
[31] A. Dowling,et al. The multideterminant model of renal disease in a remote Australian Aboriginal population in the context of early life risk factors: lower birth weight, childhood post-streptococcal glomerulonephritis, and current body mass index influence levels of albuminuria in young Aboriginal adults. , 2015, Clinical nephrology.
[32] M. Chatfield,et al. The microbiology of impetigo in Indigenous children: associations between Streptococcus pyogenes, Staphylococcus aureus,scabies, and nasal carriage , 2014, BMC Infectious Diseases.
[33] Michael W Parker,et al. A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development. , 2014, The Journal of infectious diseases.
[34] P. Rainey,et al. The Genetic Structure of Staphylococcus aureus Populations from the Southwest Pacific , 2014, PLoS ONE.
[35] S. Viali. Rheumatic heart disease in Samoa and the Pacific Nations. , 2014, Journal of primary health care.
[36] J. Kaldor,et al. Scabies community prevalence and mass drug administration in two Fijian villages , 2013, International journal of dermatology.
[37] R. Hay,et al. Toward the Global Control of Human Scabies: Introducing the International Alliance for the Control of Scabies , 2013, PLoS neglected tropical diseases.
[38] J. Mathews,et al. Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life. , 2012, Kidney international.
[39] T. Parks,et al. Streptococcal skin infection and rheumatic heart disease , 2012, Current opinion in infectious diseases.
[40] A. Cheng,et al. Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature. , 2011, The American journal of tropical medicine and hygiene.
[41] R. Daum,et al. Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic , 2010, Clinical Microbiology Reviews.
[42] M. Counahan,et al. RESEARCH ARTICLE Open Access The prevalence of common skin infections in four districts in Timor-Leste: a cross sectional survey , 2022 .
[43] R. Schwartz,et al. Impetigo update: new challenges in the era of methicillin resistance. , 2010, Cutis.
[44] J. Carapetis,et al. A Regional Initiative to Reduce Skin Infections amongst Aboriginal Children Living in Remote Communities of the Northern Territory, Australia , 2009, PLoS neglected tropical diseases.
[45] J. Carapetis,et al. High Burden of Impetigo and Scabies in a Tropical Country , 2009, PLoS neglected tropical diseases.
[46] J. Carapetis,et al. Community Management of Endemic Scabies in Remote Aboriginal Communities of Northern Australia: Low Treatment Uptake and High Ongoing Acquisition , 2009, PLoS neglected tropical diseases.
[47] P. Harris,et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.
[48] J. Carapetis,et al. Validation of an Integrated Management of Childhood Illness algorithm for managing common skin conditions in Fiji. , 2009, Bulletin of the World Health Organization.
[49] E. Popa,et al. Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis. , 2007, Rheumatology.
[50] M. McDonald,et al. Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] Mark Thomas,et al. Soil-transmitted helminth infection, skin infection, anaemia, and growth retardation in schoolchildren of Taveuni Island, Fiji. , 2005, The New Zealand medical journal.
[52] S. Hills,et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. , 2005, Bulletin of the World Health Organization.
[53] J. McCarthy,et al. Scabies: more than just an irritation , 2004, Postgraduate medical journal.
[54] M. McDonald,et al. Acute rheumatic fever: a chink in the chain that links the heart to the throat? , 2004, The Lancet. Infectious diseases.
[55] J. Carapetis,et al. Skin infections and infestations in Aboriginal communities in northern Australia , 2000, The Australasian journal of dermatology.
[56] M. Alpers,et al. Treatment with ivermectin reduces the high prevalence of scabies in a village in Papua New Guinea. , 2000, Acta tropica.
[57] A. Mancini. Bacterial skin infections in children: the common and the not so common. , 2000, Pediatric annals.
[58] J. Carlin,et al. Rheumatic heart disease in school children in Samoa , 1999, Archives of disease in childhood.
[59] S. Skull,et al. Investigation of a cluster of Staphylococcus aureus invasive infection in the top end of the Northern Territory. , 1999, Australian and New Zealand journal of medicine.
[60] J. Carapetis,et al. Success of a scabies control program in an Australian aboriginal community. , 1997, The Pediatric infectious disease journal.
[61] J. Carapetis,et al. Group A streptococcus, pyoderma, and rheumatic fever , 1996, The Lancet.
[62] M. Harris,et al. Skin infections in Tanna, Vanuatu in 1989. , 1992, Papua and New Guinea medical journal.
[63] D. Taplin,et al. Community control of scabies: a model based on use of permethrin cream , 1991, The Lancet.
[64] R. Eason,et al. Resurgent yaws and other skin diseases in the Western Province of the Solomon Islands. , 1985, Papua and New Guinea medical journal.
[65] P. Schoeffel. Dilemmas of modernization in primary health care in Western Samoa. , 1984, Social science & medicine.
[66] J. G. Walker,et al. A comparative trial of three treatment schedules for the eradication of scabies. , 1983, Journal of the American Academy of Dermatology.
[67] M. Marples. The incidence of certain skin diseases in western Samoa: a preliminary survey. , 1950, Transactions of the Royal Society of Tropical Medicine and Hygiene.